These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| | |
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE
STOCKHOLDERS MEETING TO BE HELD ON MAY 20, 2021
The proxy statement for the annual meeting and 2020 annual report to stockholders are available at
www.proxyvote.com
.
|
| |
| | | |
Page
|
| |||
| | | | | 1 | | | |
| | | | | 1 | | | |
| | | | | 7 | | | |
| | | | | 9 | | | |
| | | | | 12 | | | |
| | | | | 17 | | | |
| | | | | 19 | | | |
| | | | | 20 | | | |
| | | | | 21 | | | |
| | | | | 28 | | | |
| | | | | 30 | | | |
| | | | | 37 | | | |
| | | | | 39 | | | |
| | | | | 40 | | | |
| | | | | 41 | | | |
| | | | | 42 | | | |
| | | | | 42 | | | |
|
Name
|
| |
Age
|
| |
Position(s)
|
|
| Darin Billerbeck | | |
61
|
| |
Executive Chairman of the Board and Interim Chief Executive Officer
|
|
| Geoffrey R. Tate | | |
66
|
| | Director | |
| Lawrence G. Finch | | |
86
|
| | Director | |
| Michael B. Gustafson | | |
54
|
| | Director | |
| Geoffrey Ribar | | |
62
|
| | Director | |
|
Name
|
| |
Stock Awards
(1)
|
| |
Total
|
| ||||||
|
Darin Billerbeck
(2)
|
| | | $ | 130,503 | | | | | $ | 130,503 | | |
|
Lawrence G. Finch
|
| | | | 123,000 | | | | | | 123,000 | | |
|
Ronald C. Foster
|
| | | | 138,000 | | | | | | 138,000 | | |
|
Michael B. Gustafson
|
| | | | 130,503 | | | | | | 130,503 | | |
|
Peter Hébert
|
| | | | 123,000 | | | | | | 123,000 | | |
|
Geoffrey Ribar
|
| | | | 123,000 | | | | | | 123,000 | | |
|
Stephen J. Socolof
|
| | | | 123,000 | | | | | | 123,000 | | |
|
Geoffrey R. Tate
|
| | | | 123,000 | | | | | | 123,000 | | |
|
Name
|
| |
Option Awards
|
| |
RSU
Awards |
| ||||||
|
Darin Billerbeck
|
| | | | 42,000 | | | | | | 16,817 | | |
|
Lawrence G. Finch
|
| | | | 24,000 | | | | | | 16,203 | | |
|
Ronald C. Foster
|
| | | | 40,250 | | | | | | 17,431 | | |
|
Michael B. Gustafson
|
| | | | 40,250 | | | | | | 16,817 | | |
|
Peter Hébert
|
| | | | 24,000 | | | | | | 16,203 | | |
|
Geoffrey Ribar
|
| | | | 42,000 | | | | | | 16,203 | | |
|
Stephen J. Socolof
|
| | | | 24,000 | | | | | | 16,203 | | |
|
Geoffrey R. Tate
|
| | | | 47,287 | | | | | | 16,203 | | |
| | | |
Fiscal Years Ended December 31.
|
| |||||||||
|
Fees
|
| |
2020
|
| |
2019
|
| ||||||
| Audit (1) | | | | $ | 681 | | | | | $ | 880 | | |
|
Audit-Related
|
| | | | — | | | | | | — | | |
| Tax (2) | | | | | — | | | | | | 48 | | |
|
All Other
|
| | | | — | | | | | | — | | |
| | | | | $ | 681 | | | | | $ | 928 | | |
|
Name and position
|
| |
Number of
shares subject to grant (#) |
| |||
|
Kevin Conley, Former President and Chief Executive Officer
|
| | | | 655,276 | | |
|
Daniel Berenbaum, Chief Financial Officer
|
| | | | 105,770 | | |
|
Sanjeev Aggarwal, Vice President Technology R&D
|
| | | | 182,944 | | |
|
All Current Executive Officers as a Group
|
| | | | 573,677 | | |
|
All Current Non-Executive Directors as a Group
|
| | | | 451,233 | | |
|
All Employees as a Group (including all current non-executive officers)
|
| | | | 4,629,785 | | |
| Nominees for Director: | | | | | | | |
|
Darin Billerbeck
|
| | | | 145,359 | | |
|
Geoffrey R. Tate
|
| | | | 80,264 | | |
|
Lawrence G. Finch
|
| | | | 53,131 | | |
|
Michael B. Gustafson
|
| | | | 70,609 | | |
|
Geoffrey Ribar
|
| | | | 68,131 | | |
|
Each Associate of any Director, Executive Officer or Director Nominee
|
| | | | — | | |
|
Each Other Current 5% Holder or Future 5% Recipient
|
| | | | — | | |
|
Name
|
| |
Age
|
| |
Position(s)
|
|
| Darin Billerbeck | | |
61
|
| | Executive Chairman of the Board and Interim Chief Executive Officer | |
| Daniel Berenbaum* | | |
51
|
| | Chief Financial Officer | |
|
Sanjeev Aggarwal, Ph.D.
|
| |
53
|
| | Vice President, Technology R&D | |
| Troy Winslow | | |
53
|
| | Vice President, Sales and Marketing | |
|
Name and
Principal Position |
| |
Year
|
| |
Salary
|
| |
Bonus
|
| |
Stock
Awards (1) |
| |
Stock
Options (1) |
| |
Non-Equity
Incentive Plan Compensation |
| |
All Other
Compensation |
| |
Total
|
| ||||||||||||||||||||||||
|
Kevin Conley
(2)
|
| | | | 2020 | | | | | $ | 400,000 | | | | | $ | 200 | | | | | $ | 217,498 | | | | | $ | 175,718 | | | | | $ | — | | | | | $ | 541,399 (3) | | | | | $ | 1,334,815 | | |
|
Former President and
|
| | | | 2019 | | | | | $ | 400,000 | | | | | $ | 1,000 | | | | | $ | 95,250 | | | | | $ | 232,068 | | | | | $ | 180,000 (4) | | | | | $ | 700 | | | | | $ | 909,018 | | |
|
Chief Executive Officer
|
| | | | | | | | | ||||||||||||||||||||||||||||||||||||||||
|
Daniel Berenbaum
(5)
|
| | | | 2020 | | | | | $ | 137,097 | | | | | $ | 30,000 (6) | | | | | $ | 269,000 | | | | | $ | 180,790 | | | | | $ | 29,823 (4) | | | | | $ | 348 | | | | | $ | 647,058 | | |
| Chief Financial Officer | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Sanjeev Aggarwal, Ph.D.
(5)
|
| | | | 2020 | | | | | $ | 250,599 | | | | | $ | 1,033 | | | | | $ | 61,833 | | | | | $ | 69,641 | | | | | $ | 32,327 (4) | | | | | $ | 778 | | | | | $ | 416,211 | | |
|
Vice President, Technology R&D
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Name
|
| |
Stock Options
Awarded (#) |
| |
RSUs
Awarded (#) |
| ||||||
|
Kevin Conley
|
| | | | 105,000 | | | | | | 15,000 | | |
|
Daniel Berenbaum
|
| | | | 50,000 | | | | | | 50,000 | | |
|
Sanjeev Aggarwal
|
| | | | 45,000 | | | | | | 7,500 | | |
| | | |
Option Awards
|
| |
Stock Awards
|
| ||||||||||||||||||||||||||||||
| | | |
Number of Securities Underlying
Unexercised Options |
| |
Option Exercise
Price($) |
| |
Option
Expiration Date |
| |
Number of Shares
or Units of Stock That Have Not Yet Vested(#) |
| |
Market Value of
Shares or Units of Stock That Have Not Yet Vested($) (1) |
| |||||||||||||||||||||
|
Name
|
| |
Exercisable(#)
|
| |
Unexercisable(#)
|
| ||||||||||||||||||||||||||||||
|
Kevin Conley
|
| | | | 16,250 | | | | | | — | | | | | | 7.88 | | | | | | 3/23/2027 | | | | | | | | | | | | | | |
| | | | | | 325,000 | | | | | | 75,000 (2) | | | | | | 7.64 (3) | | | | | | 8/31/2027 | | | | | | | | | | | | | | |
| | | | | | 27,500 | | | | | | 32,500 (4) | | | | | | 6.35 | | | | | | 2/10/2029 | | | | | | | | | | | | | | |
| | | | | | — | | | | | | 60,000 (5) | | | | | | 2.50 | | | | | | 3/24/2030 | | | | | | | | | | | | | | |
| | | | | | — | | | | | | 45,000 (6) | | | | | | 2.56 | | | | | | 4/6/2030 | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 26,250 (7) | | | | | | 120,750 | | |
|
Daniel Berenbaum
|
| | | | — | | | | | | 50,000 (8) | | | | | | 5.38 | | | | | | 8/17/2030 | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 50,000 (9) | | | | | | 230,000 | | |
|
Sanjeev Aggarwal
|
| | | | 1,923 | | | | | | — | | | | | | 4.42 | | | | | | 6/18/2022 | | | | | | | | | | | | | | |
| | | | | | 20,705 | | | | | | — | | | | | | 4.42 | | | | | | 5/12/2024 | | | | | | | | | | | | | | |
| | | | | | 24,768 | | | | | | — | | | | | | 6.63 (10) | | | | | | 7/11/2026 | | | | | | | | | | | | | | |
| | | | | | 6,875 | | | | | | 3,125 (11) | | | | | | 9.12 | | | | | | 3/12/2028 | | | | | | | | | | | | | | |
| | | | | | 9,166 | | | | | | 10,834 (12) | | | | | | 6.35 | | | | | | 2/10/2029 | | | | | | | | | | | | | | |
| | | | | | — | | | | | | 30,000 (13) | | | | | | 2.23 | | | | | | 3/23/2030 | | | | | | | | | | | | | | |
| | | | | | — | | | | | | 15,000 (14) | | | | | | 2.56 | | | | | | 4/06/2030 | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 13,500 (15) | | | | | | 62,100 | | |
|
Name of Beneficial Owners
|
| |
Shares
Owned |
| |
Shares
Exercisable Within 60 days |
| |
Total
Shares Beneficially Owned |
| |
Percentage of
Beneficial Ownership |
| ||||||||||||
| 5% Stockholders: | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Entities affiliated with NV Partners
(1)
|
| | | | 2,260,991 | | | | | | — | | | | | | 2,260,991 | | | | | | 11.8 % | | |
|
AWM Investment Company, Inc.
(2)
|
| | | | 1,878,597 | | | | | | — | | | | | | 1,878,597 | | | | | | 9.8 % | | |
|
Entities affiliated with Sigma Partners
(3)
|
| | | | 1,240,366 | | | | | | — | | | | | | 1,240,366 | | | | | | 6.5 % | | |
| Directors and Named Executive Officers: | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Darin Billerbeck
|
| | | | 23,672 | | | | | | 51,166 | | | | | | 74,838 | | | | | | * | | |
|
Lawrence G. Finch
(4)
|
| | | | 324,983 | | | | | | 24,000 | | | | | | 348,983 | | | | | | 1.8 % | | |
|
Ronald C. Foster
|
| | | | 17,733 | | | | | | 40,250 | | | | | | 57,983 | | | | | | * | | |
|
Michael B. Gustafson
|
| | | | 30,099 | | | | | | 40,250 | | | | | | 70,349 | | | | | | * | | |
|
Peter Hébert
|
| | | | 14,892 | | | | | | 24,000 | | | | | | 38,892 | | | | | | * | | |
|
Stephen J. Socolof
(5)
|
| | | | 2,275,883 | | | | | | 24,000 | | | | | | 2,299,883 | | | | | | 12.0 % | | |
|
Geoffrey Ribar
|
| | | | 11,892 | | | | | | 36,166 | | | | | | 48,058 | | | | | | * | | |
|
Geoffrey R. Tate
(6)
|
| | | | 118,252 | | | | | | 46,326 | | | | | | 164,578 | | | | | | * | | |
|
Daniel Berenbaum
|
| | | | 3,849 | | | | | | — | | | | | | 3,849 | | | | | | * | | |
|
Sanjeev Aggarwal
|
| | | | 14,713 | | | | | | 82,022 | | | | | | 96,735 | | | | | | * | | |
|
Kevin Conley
|
| | | | 102,462 | | | | | | — | | | | | | 102,462 | | | | | | * | | |
| All directors and executive officers as a group | | | | | | | | | | | | | | | | | | | | | | | | | |
|
(11 persons)
(7)
|
| | | | 2,835,968 | | | | | | 406,616 | | | | | | 3,242,584 | | | | | | 16.6 % | | |
|
Plan Category
|
| |
Number of Securities to
be Issued Upon Exercise of Outstanding Options, Warrants or Rights (a) |
| |
Weighted Average
Exercise Price of Outstanding Options, Warrants or Rights (b) |
| |
Number of Securities
Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities reflected in Column (a)) (c) |
| |||||||||
|
Equity compensation plans approved by security holders
(1)
|
| | | | 2,689,647 | | | | | $ | 4.72 | | | | | | 708,102 | | |
|
Equity compensation plans not approved by
security holders |
| | | | — | | | | | | — | | | | | | — | | |
|
Total
|
| | |
|
2,689,647
|
| | | | | | | | | |
|
708,102
|
| |
| By: |
|
| Name: |
|
| Its: |
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|